Pharmaceutical - Novo Nordisk

Filter

Current filters:

Novo Nordisk

Popular Filters

6751 to 6775 of 6831 results

Nigerian government plans local production of anti-malaria drugs

06-05-2011

To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the…

GenericsMarkets & MarketingPharmaceuticalPoliticsRest of the WorldTropical diseases

Australian generic drugmakers welcome IP law to encourage R&D investment

06-05-2011

Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…

Asia-PacificGenericsPatentsPharmaceutical

Chile remains on USTR Priority Watch list

06-05-2011

The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

Asthma pill more user-friendly than inhalers - and no less effective

06-05-2011

Rarely prescribed asthma drug in tablet form are easier to use and just as effective as conventional…

AccolateGlaxoSmithKlineMerck & CoPharmaceuticalResearchRespiratory and PulmonarySingulair

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

05-05-2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

New study reveals risks with Roche’s Avastin for wet AMD versus Lucentis

05-05-2011

A new Medicare analysis conducted by Johns Hopkins University in the USA was presented yesterday at the…

AvastinLucentisNovartisOphthalmicsPharmaceuticalResearchRoche

Bayer would consider “merger of equals” for its health care unit, CEO tells Bloomberg

05-05-2011

Although German drugs and crop sciences major Bayer AG (BAY: DE) is fine with doing nothing, a “merger…

BayerMergers & AcquisitionsPharmaceutical

293 new drugs await regulatory approval in Turkey

05-05-2011

A survey of 33 companies from the research-based pharmaceutical industry in Turkey found that the number…

EuropePharmaceuticalRegulation

Cephalon 1st-qtr 2011 sales leap 28% but below consensus forecasts

05-05-2011

US drugmaker Cephalon (Nasdaq: CEPH), which earlier this week agreed to be acquired by Israel’s…

CephalonFinancialPharmaceutical

Ipsen reports strong drug sales for first quarter 2011

05-05-2011

French drugmaker Ipsen (Euronext: IPN) reported a 6.1% increase in sales to 285.8 million euros ($423.2…

FinancialIpsenPharmaceutical

Non-Hodgkins lymphoma drug market set to more than double by 2019

05-05-2011

Driven by the launches of premium-priced therapies, the non-Hodgkin’s lymphoma drug market will…

ArzerraGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalRituxanrituximabRoche

USA’s FDA and FTC act to remove fraudulent STD products from the market

05-05-2011

The US Food and Drug Administration has joined forces with the Federal Trade Commission in a joint effort…

North AmericaPharmaceuticalRegulationReproductive

US shortages of key drugs are endangering patients

04-05-2011

In the USA, doctors, hospitals and federal regulators are struggling to cope with an unprecedented surge…

Markets & MarketingNorth AmericaPharmaceutical

Pfizer 1st-qtr 2011 beats forecasts, as profits rise 10%

04-05-2011

Pfizer (NYSE: PFE), the world’s largest pharmaceutical company by sales, beat analysts’ consensus…

FinancialPfizerPharmaceutical

US FDA clears Boehringer and Lilly’s diabetes drug Tradjenta

04-05-2011

The US Food and Drug Administration has approved Tradjenta (linagliptin), for use along with diet and…

Boehringer IngelheimDiabetesEli LillylinagliptinNorth AmericaPharmaceuticalRegulationTradjenta

Swiss IVAL Pharma to invest $150 million in Uzbekistan plant to make insulin and other products

04-05-2011

Switzerland-based IVAL Pharma AG is considering investing up to $150 million in the construction of a…

DiabetesEuropeFinancialIVAL PharmaMarkets & MarketingPharmaceutical

Astellas recruits Big Pharma execs to strengthen US global development team

04-05-2011

Astellas Pharma Global Development (APGD), a subsidiary of Japanese drug major Astellas Pharma (TSE:…

Astellas PharmaManagementPharmaceutical

Merck & Co 1st-qtr 2011 profits triple, beating analysts’ forecasts

03-05-2011

US drugs giant Merck & Co (NYSE: MRK) posted a first-quarter 2011 profit of $1.04 billion, compared with…

FinancialMerck & CoPharmaceutical

Bristol-Myers Squibb sees 1st-qtr 2011 profit jump 33%; key R&D milestones

03-05-2011

US drug major Bristol-Myers Squibb Company (NYSE: BMY) last Thursday announced first quarter 2011 results…

Bristol-Myers SquibbFinancialPharmaceutical

6751 to 6775 of 6831 results

Back to top